Press Releases from Exactitude Consultancy (20114 total)
Postmenopausal Osteoporosis Market Massive Growth opportunity Ahead
Introduction
Postmenopausal osteoporosis is one of the most common metabolic bone disorders, characterized by reduced bone density and increased fracture risk due to declining estrogen levels…
Phosphoglucomutase 1 Deficiency Market Massive Growth opportunity Ahead
Phosphoglucomutase 1 Deficiency Market Outlook 2024-2034: Rare Disease Awareness, Genetic Testing, and Emerging Therapies Drive Growth
Introduction
Phosphoglucomutase 1 (PGM1) deficiency, also referred to as PGM1-CDG (congenital…
Maple Syrup Urine Disease (MSUD) Market Massive Growth opportunity Ahead
Introduction
Maple syrup urine disease (MSUD) is a rare, inherited metabolic disorder caused by a deficiency in the branched-chain. The condition is named after the characteristic…
Locally Advanced Pancreatic Cancer (LAPC) Market Growth, Applications, Innovatio …
Introduction
Pancreatic cancer remains one of the deadliest malignancies, with limited treatment options and poor survival outcomes. Locally advanced pancreatic cancer (LAPC) is an intermediate stage…
Diabetic Macular Edema Market Massive Growth opportunity Ahead
Introduction
Diabetic macular edema (DME) is one of the leading causes of vision impairment among people with diabetes, characterized by fluid leakage into the macula, the…
Cystinosis Market 2025-2034 Business Outlook, Critical Insight and Growth
Introduction
Cystinosis is a rare, inherited lysosomal storage disorder caused by the accumulation of cystine within cells, leading to progressive damage to multiple organs, including the…
Somatotropin Deficiency Market Growth, Applications, Innovations and Business Ou …
Introduction
Somatotropin deficiency, commonly referred to as growth hormone deficiency (GHD), is a rare endocrine disorder characterized by inadequate secretion of growth hormone (GH) from the…
Endogenous Cushing's Syndrome Market to Reach USD 1.9 Billion by 2034
Endogenous Cushing's Syndrome (CS) is a rare but serious endocrine disorder caused by chronic exposure to elevated cortisol levels due to the body's own overproduction.…
Secondary Hyperparathyroidism Market Growth, Trends, Consumer Demand and Key Opp …
Introduction
Secondary hyperparathyroidism (SHPT) is a frequent and serious complication of chronic kidney disease (CKD), characterized by excessive secretion of parathyroid hormone (PTH) due to impaired…
Familial Amyloid Polyneuropathy (FAP) Market to Reach USD 2.4 Billion by 2034
Familial Amyloid Polyneuropathy (FAP) is a progressive, inherited rare disease caused by mutations in the transthyretin (TTR) gene, leading to the buildup of misfolded amyloid…
Renal Insufficiency Market Insights and Future Outlook
Introduction
Renal insufficiency, also referred to as chronic kidney disease (CKD) or kidney function decline, is a progressive condition where the kidneys fail to filter blood…
Familial Lipoprotein Lipase Deficiency (LPLD) market is expected to reach USD 4. …
Familial Lipoprotein Lipase Deficiency (LPLD) is an ultra-rare, inherited metabolic disorder caused by mutations in the lipoprotein lipase (LPL) gene, which is responsible for breaking…
Goitre Market is expected to reach USD 4.5 billion by 2034
Goitre, an abnormal enlargement of the thyroid gland, is one of the most recognized thyroid disorders worldwide. It may result from iodine deficiency, autoimmune conditions…
Impaired Glucose Tolerance Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Impaired glucose tolerance (IGT) is a pre-diabetic state of hyperglycemia characterized by blood glucose levels that are higher than normal but not high enough to…
Underactive Bladder Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Underactive bladder (UAB) is a chronic, often underdiagnosed condition characterized by decreased detrusor muscle activity, leading to incomplete bladder emptying, infrequent urination, and urinary retention.…
Hereditary Hemochromatosis (HH) Market to Reach USD 5.1 Billion by 2034
Hereditary Hemochromatosis (HH) is a genetic disorder characterized by excessive absorption and storage of dietary iron, leading to iron overload in organs such as the…
Graves' Disease Market New Product Development & Latest Trends
Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overproduction of thyroid hormones, through antibodies that stimulate the thyroid gland. It is among the…
Heterozygous Familial Hypercholesterolemia (HeFH) Market to Reach USD 12 Billion …
Heterozygous Familial Hypercholesterolemia (HeFH) is a common yet underdiagnosed genetic disorder that significantly elevates low-density lipoprotein cholesterol (LDL-C) levels from birth. Affecting approximately 1 in…
Homocystinuria Market to Reach USD 1.5 Billion by 2034
Homocystinuria is a rare inherited metabolic disorder caused by a deficiency of enzymes involved in the metabolism of the amino acid methionine, most commonly cystathionine…
Primary Hyperoxaluria Market New Product Development & Latest Trends
Introduction
Primary hyperoxaluria (PH) is a group of rare, inherited metabolic disorders characterized by the overproduction of oxalate in the liver, leading to recurrent kidney stones,…
Hyperammonemia Market to Reach USD 2.5 Billion by 2034
Hyperammonemia is a metabolic condition characterized by abnormally elevated levels of ammonia in the blood, resulting from impaired detoxification in the liver or deficiencies in…
Hypertriglyceridemia Market is expected to reach USD 39 billion by 2034
Hypertriglyceridemia is a common lipid disorder characterized by elevated levels of triglycerides in the blood, often associated with obesity, diabetes, metabolic syndrome, and genetic predisposition.…
Hypoglycemia Market to Reach USD 2.5 Billion by 2034
Hypoglycemia, commonly defined as abnormally low blood glucose levels, is a serious condition that often affects individuals with diabetes receiving insulin or other glucose-lowering therapies.…
Insulin Resistance Market Massive Growth opportunity Ahead
Introduction
Insulin resistance, a condition where the body's cells fail to respond effectively to insulin, plays a central role in the development of type 2 diabetes,…
Idiopathic Short Stature (ISS) Market to Reach USD 3.5 Billion by 2034
The global Idiopathic Short Stature Market size was valued at USD 1.8 billion in 2024 and is projected to reach USD 3.5 billion by 2034,…
Phenylnuria (PKU) Market is expected to reach USD 1.1 billion by 2034
Phenylnuria (PKU) is a rare, inherited metabolic disorder caused by a deficiency in phenylalanine hydroxylase (PAH), an enzyme required to metabolize the amino acid phenylalanine.…
Hypopituitarism Market Detailed Industry Report Analysis 2025-2034
Introduction
Hypopituitarism is a rare but serious condition in which the pituitary gland fails to produce adequate levels of one or more essential hormones. These deficiencies…
Acute Pancreatitis (AP) Market to Reach USD 5.5 Billion by 2034
Acute Pancreatitis (AP) is a sudden inflammation of the pancreas that can range from mild discomfort to life-threatening illness. It is often caused by gallstones,…
Hyperglycemia Market Massive Growth opportunity Ahead
Introduction
Hyperglycemia, or high blood glucose, is a common and serious condition associated with diabetes mellitus and other metabolic disorders. It is not only a key…
Congenital Adrenal Hyperplasia (CAH) Market to Reach USD 2.4 Billion by 2034
Congenital Adrenal Hyperplasia (CAH) is a group of inherited genetic disorders that affect the adrenal glands, leading to impaired cortisol production and, in some cases,…
Liver Cirrhosis Patient Pool Analysis Market to Reach USD 12 Billion by 2034
Liver cirrhosis is a late-stage liver disease characterized by irreversible scarring (fibrosis) of liver tissue, often caused by chronic hepatitis infections, excessive alcohol consumption, nonalcoholic…
Homozygous Familial Hypercholesterolemia Market Outlook 2024-2034
Introduction
Homozygous familial hypercholesterolemia (HoFH) is a rare, life-threatening genetic disorder characterized by extremely high cholesterol levels from birth. Patients with HoFH are at a very…
HIV-Associated Lipodystrophy Market Growth, Trends, Consumer Demand and Key Oppo …
Introduction
The HIV-associated lipodystrophy market is gaining increased attention as healthcare providers, researchers, and policymakers work to address one of the most challenging complications faced by…
POMC & LEPR Deficiency Obesity Market to Reach USD 2.7 Billion by 2034
Proopiomelanocortin (POMC) deficiency obesity and leptin receptor (LEPR) deficiency obesity are rare, inherited forms of monogenic obesity characterized by early-onset, severe, and persistent weight gain.…
Sandhoff Disease Market to Reach USD 1.2 Billion by 2034
Sandhoff disease is a rare, inherited lysosomal storage disorder caused by mutations in the HEXB gene, leading to a deficiency in the beta-hexosaminidase A and…
Severe Hypoglycemia Market to Reach USD 3.2 Billion by 2034
Severe hypoglycemia is a critical, potentially life-threatening condition marked by dangerously low blood glucose levels, most often occurring in patients with diabetes mellitus treated with…
Turner Syndrome Market to Reach USD 2.8 Billion by 2034
Turner Syndrome is a rare chromosomal condition that affects females, occurring when one of the X chromosomes is missing or partially missing. It is associated…
Diabetic Foot Ulcers (DFU) Market to Reach USD 7.8 Billion by 2034
Diabetic Foot Ulcers (DFUs) are among the most serious and costly complications of diabetes, characterized by chronic wounds that can lead to infection, hospitalization, and…
Isovaleric Acidemia (IVA) Market to Reach USD 920 Million by 2034
Isovaleric Acidemia (IVA) is a rare inherited metabolic disorder caused by mutations in the IVD gene, leading to a deficiency of isovaleryl-CoA dehydrogenase. This enzyme…
Lymphedema Market to Reach USD 7.4 Billion by 2034
Lymphedema is a chronic, progressive condition characterized by the accumulation of lymphatic fluid in the body's tissues, leading to swelling, discomfort, and recurrent infections. It…
Metachromatic Leukodystrophy (MLD) market is expected to reach USD 1.1 billion b …
Metachromatic Leukodystrophy (MLD) is a rare, inherited lysosomal storage disorder caused by a deficiency in the enzyme arylsulfatase A (ARSA), leading to toxic accumulation of…
Pituitary Stalk Interruption Syndrome (PSIS) market is expected to reach USD 2.5 …
Pituitary Stalk Interruption Syndrome (PSIS) is a rare congenital disorder characterized by an absent or thin pituitary stalk, hypoplastic anterior pituitary, and ectopic posterior pituitary.…
Pouchitis Market is expected to reach USD 1.2 billion by 2034
Pouchitis is the most common long-term complication following ileal pouch-anal anastomosis (IPAA) surgery, primarily performed for patients with ulcerative colitis and familial adenomatous polyposis. It…
Cell Therapy Packaging Market to Surpass USD 3.2 Billion by 2034
Cell therapies have emerged as one of the most promising innovations in modern medicine, offering transformative potential in treating cancer, genetic disorders, and autoimmune diseases.…
Gaucher's Disease Market New Product Development & Latest Trends
Introduction
Gaucher's disease, a rare inherited lysosomal storage disorder, has long posed challenges for patients and healthcare systems. Characterized by the accumulation of fatty substances in…
Cold Chain Logistics Market to Reach USD 400 Billion by 2034
Cold chain logistics has become a critical backbone of modern trade, ensuring temperature-sensitive products such as food, pharmaceuticals, vaccines, and chemicals reach consumers safely and…
Diabetic Neuropathic Pain Market New Product Development & Latest Trends
Introduction
Diabetes is not just a metabolic disorder-it carries a host of complications, among which Diabetic Neuropathic Pain (DNP) is one of the most debilitating. Affecting…
Aseptic Filling Machine Market Set to Nearly Double by 2034 Driven by Food & Pha …
In an era where hygiene, safety, and efficiency are paramount across food and pharmaceutical industries, aseptic filling machines are becoming a cornerstone of modern production.…
Familial Hypercholesterolemia Market Detailed Industry Report Analysis 2025-2034
Introduction
Familial Hypercholesterolemia (FH) is a genetic disorder characterized by dangerously high cholesterol levels, often leading to early cardiovascular disease. Affecting millions worldwide, FH is frequently…
Non-Viral Transfection Reagents Market to Double by 2034, Boosted by Biopharma a …
As biotechnology continues to transform healthcare and life sciences, transfection has become an indispensable tool in genetic research and therapeutic development. Transfection refers to the…
Go To Page: 21 22 23 24 25 26 27 28 29 30 301 302 303 304 305 306 307 308 309 310
